Direct oral Xa inhibitors for the treatment of venous thromboembolism after bariatric surgery
Blood Adv
.
2023 Jan 24;7(2):224-226.
doi: 10.1182/bloodadvances.2021006696.
Authors
Margarita Kushnir
1
,
Radhika Gali
1
,
Mariam Alexander
1
,
Henny H Billett
1
Affiliation
1
Division of Hematology, Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY.
PMID:
35640233
PMCID:
PMC9841032
DOI:
10.1182/bloodadvances.2021006696
No abstract available
MeSH terms
Anticoagulants / therapeutic use
Bariatric Surgery* / adverse effects
Humans
Rivaroxaban
Venous Thromboembolism* / drug therapy
Venous Thromboembolism* / etiology
Substances
Anticoagulants
Rivaroxaban